Health ❯ Healthcare ❯ Clinical Trials

Outcomes Research

Live Birth Success Rates Survival Analysis Adverse Clinical Events Cardiovascular Outcomes

Evolocumab Cuts First Cardiovascular Events in High-Risk Adults, NEJM Trial Shows

Peer-reviewed results support earlier, intensive LDL lowering in primary prevention.

ESC Trials Back Shorter Antiplatelet Therapy for Selected MI Patients